Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07692269

Mindfulness Intervention for Emotional Distress: An EEG Study

This is a randomized controlled trial examining the efficacy and neural mechanisms of a standardized Mindfulness Intervention for Emotional Distress (MIED) in adults with subclinical emotional distress. One hundred and sixty participants will be randomly assigned to either an 8-week MIED program or an 8-week Progressive Muscle Relaxation (PMR) active control. The primary aim is to evaluate whether MIED reduces anxiety symptoms and reshapes multilevel emotional processing as measured by multimodal EEG (resting-state FAA/theta, Fast Periodic Visual Stimulation, and event-related potentials). Assessments occur at baseline (T1), post-intervention (T2), and 1-month follow-up.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–50 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Peking University, School of Psychological and Cognitive Sciences

Beijing, Beijing Municipality, China

Location status: Recruiting

Location contact

Xinghua Liu, PHD

CONTACT

[email protected]

+86 13371669818

About this study

Background. Emotional distress is a subclinical mental health condition characterized by persistent anxiety, depression, stress, and emotion dysregulation. Mindfulness interventions have shown efficacy across transdiagnostic emotional disorders, yet their neurocognitive mechanisms remain incompletely understood.

Objective. This study aims to (1) verify the dynamic intervention effects of MIED on emotional distress; (2) reveal neuroplastic changes across multiple levels of emotional processing; (3) explore associations between neural changes and symptom improvement; and (4) examine whether strategy acquisition is linked to neural remodeling.

Design. This is a two-arm, parallel-group, randomized controlled trial with single (outcomes assessor) blinding. Participants (N = 160) aged 18-50 with elevated psychological distress (K10 > 21) will be randomized (1:1; block sizes 4 and 6) to:

Experimental arm: MIED - 8 weeks of weekly 2.5-hour group sessions plus daily 15-minute app-based(IMIED) home practice.

Active comparator arm: PMR - 8 weeks of structurally matched weekly 2.5-hour group sessions plus daily 15-minute audio home practice.

Assessments. Baseline (T1), post-intervention (T2, within 2 weeks after Week 8), and 1-month follow-up (online). During the intervention, brief online tracking (GAD-7, PHQ-9) occurs at Weeks 2, 4, and 6.

Neuroimaging. Multimodal EEG includes: (a) 5-minute resting-state EEG (FAA, theta power); (b) Fast Periodic Visual Stimulation (FPVS; 6 Hz base frequency, 1.2 Hz oddball for emotional faces) to index automatic emotional processing; (c) Task-based ERP ( LPP at 400-800 ms ) during emotional picture rating to index controlled emotional processing.

Primary Mechanistic Outcome. LPP early-window (400-800 ms) mean amplitude under negative stimulus conditions.

Statistical Analysis. Primary efficacy analyses will use linear mixed-effects models (LMM) under the intention-to-treat (ITT) principle. Missing data will be handled by restricted maximum likelihood (REML) assuming MAR, with multiple imputation as a sensitivity analysis. Hierarchical multiple comparison control: primary outcome (GAD-7) at α = 0.05 (two-sided); key secondary outcome (PHQ-9) reported with nominal and corrected p-values; remaining psychological and EEG measures corrected by Benjamini-Hochberg FDR.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults aged 18-50 years Kessler Psychological Distress Scale (K10) score > 21 No systematic mindfulness or progressive muscle relaxation practice in the past 6 months (frequency < 1 time per week) Normal or corrected-to-normal vision Voluntary participation with signed informed consent

Exclusion criteria

  • Prior diagnosis of schizophrenia, bipolar disorder, or other severe mental disorders by a psychiatrist Suicidal plan, self-injury, or need for emergency psychological crisis intervention in the past month Currently receiving systematic psychotherapy or participating in other psychological intervention programs Started psychiatric medication within the past 3 months or on an unstable medication dosage History of epilepsy, severe brain injury, or other neurological disorders that may affect EEG measurement Severe vision or hearing impairment or other conditions preventing completion of study procedures

Treatment and study plan

MIED

Behavioral

A standardized 8-week transdiagnostic mindfulness intervention (MIED) based on the Unified Protocol and contemporary mindfulness theory. Participants attend weekly 2.5-hour group sessions and complete daily 15-minute home practice via a mobile app (iMIED). Core practices include mindful breathing, body scan, mindful walking, and loving-kindness meditation. The program emphasizes four key strategies: engagement with life, distress tolerance, cognitive flexibility, and emotion-driven behavioral regulation. All sessions follow a structured manual to ensure fidelity.

PMR

Behavioral

A structured 8-week Progressive Muscle Relaxation program matched to MIED in frequency, duration, and format. Participants attend weekly 2.5-hour group sessions and complete daily 15-minute audio-guided home practice. The program progresses from systematic tension-release of major muscle groups to full-body relaxation, controlling for non-specific therapeutic factors (group support, time, expectancy). All sessions are manualized to ensure consistent delivery.

Primary outcomes

  1. Generalized Anxiety Disorder-7(GAD-7)

    Time frame: Baseline (T1, Week 0), Week 2, Week 4, Week 6, post-intervention (T2, Week 8), and 1-month follow-up (Week 12)

    The GAD-7 is a 7-item self-report measure of anxiety symptom severity over the past 2 weeks. Total scores range from 0 to 21. The primary analysis examines the Group × Time interaction using linear mixed-effects models across all six assessment points (Weeks 0, 2, 4, 6, 8, and 12).

Secondary outcomes

  1. Patient Health Questionnaire(PHQ-9)

    Time frame: Baseline (T1, Week 0), Week 2, Week 4, Week 6, post-intervention (T2, Week 8), and 1-month follow-up (Week 12)

    The Patient Health Questionnaire-9 (PHQ-9) is a 9-item self-report measure assessing the severity of depressive symptoms over the past two weeks. Total scores range from 0 to 27, with higher scores indicating more severe depressive symptoms (worse outcome).

  2. Five Facet Mindfulness Questionnaire-20 (FFMQ-20)

    Time frame: Baseline (T1,week 0) and post-intervention (T2, Week 8)

    The Five Facet Mindfulness Questionnaire-20 (FFMQ-20) is a 20-item self-report measure assessing trait mindfulness across five facets. Total scores range from 20 to 100, with higher scores indicating greater mindfulness (better outcome).

  3. Distress Tolerance Scale (DTS)

    Time frame: Baseline (T1,week 0) and post-intervention (T2,week 8)

    The Distress Tolerance Scale (DTS) is a 15-item self-report measure assessing an individual's perceived ability to tolerate and manage emotional distress. Total scores range from 15 to 75, with higher scores indicating greater distress tolerance (better outcome).

  4. Cognitive Flexibility Inventory (CFI)

    Time frame: Baseline (T1,week0) and post-intervention (T2,week8)

    The Cognitive Flexibility Inventory (CFI) is a 20-item self-report measure assessing cognitive flexibility. Total scores range from 20 to 140, with higher scores indicating greater cognitive flexibility (better outcome).

  5. Excessive Emotional Behavior Scale (EEBS)

    Time frame: Baseline (T1,week 0) and post-intervention (T2,week8)

    EEBS is a self-report measure assessing the tendency to engage in excessive emotional behaviors in response to emotional distress. Higher scores indicate greater levels of excessive emotional behavior.

  6. Engagement with Life Scale (ELS)

    Time frame: Baseline (T1,week0) and post-intervention (T2,week8)

    ELS is a self-report measure assessing the extent to which individuals engage in meaningful and valued life activities despite experiencing emotional distress. Higher scores indicate greater engagement with life.

  7. Chinese Perceived Stress Scale (CPSS)

    Time frame: baseline(T1,week 0),post-intervention(T2,week8)

    The Chinese Perceived Stress Scale-14 (CPSS-14) is a 14-item self-report measure assessing perceived stress during the past month. Total scores range from 0 to 56, with higher scores indicating greater perceived stress (worse outcome).

  8. Late Positive Potential (LPP) early window (400-800 ms)

    Time frame: Baseline (T1,week 0) and post-intervention (T2,week 8)

    Late Positive Potential (LPP; 400-800 ms mean amplitude) is an ERP component reflecting sustained controlled processing of emotional stimuli. Mean LPP amplitude within the 400-800 ms time window will be quantified at CPz, Cz, P3, Pz, and P4 during a 20-minute emotional picture rating task. Based on the best available evidence and theoretical rationale from previous mindfulness and emotion regulation studies, LPP was selected as a candidate mechanistic outcome.

  9. Frontal Alpha Asymmetry (FAA)

    Time frame: Baseline (T1,week 0) and post-intervention (T2,week 8)

    Frontal Alpha Asymmetry (FAA; 8-13 Hz log-transformed alpha power difference) is a resting-state EEG measure reflecting hemispheric asymmetry in frontal cortical activity and has been associated with affective processing, emotion regulation, and approach-withdrawal motivational tendencies. FAA will be calculated as the log-transformed alpha power difference between homologous frontal electrode pairs (e.g., ln[F4] - ln[F3]) during a 5-minute resting-state EEG recording. Based on the best available evidence and theoretical rationale from previous mindfulness and emotion regulation studies, FAA was selected as a candidate mechanistic outcome.

  10. Frontal theta power

    Time frame: Baseline (T1,week 0) and post-intervention (T2,week 8)

    Frontal theta power (4-8 Hz) is a resting-state EEG measure associated with cognitive control, attentional regulation, and emotion regulation. Absolute or relative theta power within the 4-8 Hz frequency band will be quantified from frontal electrodes (e.g., Fz, F3, and F4) during a 5-minute resting-state EEG recording. Based on the best available evidence and theoretical rationale from previous mindfulness and cognitive control studies, frontal theta power was selected as a candidate mechanistic outcome.

  11. Fast Periodic Visual Stimulation Signal-to-Noise Ratio (FPVS-SNR)

    Time frame: Baseline (T1,week 0) and post-intervention (T2,week 8)

    Fast Periodic Visual Stimulation Signal-to-Noise Ratio (FPVS-SNR) is an EEG-derived measure quantifying neural responses to periodically presented emotional visual stimuli. Change in FPVS-SNR from baseline to post-intervention will be assessed during the emotional fast periodic visual stimulation task.Based on the best available evidence and theoretical rationale, FPVS-SNR was selected as a candidate mechanistic outcome to assess changes in visual emotional processing following the intervention.

  12. Kessler Psychological Distress Scale (K10)

    Time frame: Baseline (T1,week 0) and post-intervention (T2, Week 8)]

    The Kessler Psychological Distress Scale (K10) is a 10-item self-report measure assessing non-specific psychological distress during the past four weeks. Total scores range from 10 to 50, with higher scores indicating greater psychological distress (worse outcome).

Other outcomes

  1. Meditation-Related Adverse Events Scale (MRAES-MBP)

    Time frame: Week 2, Week 4, Week 6, and Week 8

    The MRAES-MBP is a self-report measure assessing meditation-related adverse events experienced during participation in mindfulness-based programs, including their occurrence and severity.

  2. Simplified adverse events questionnaire

    Time frame: Week 2, Week 4, Week 6, and Week 8

    A simplified safety monitoring questionnaire administered biweekly to the PMR group to assess somatic discomfort and emotional reactions related to muscle relaxation practice.

  3. Credibility/Expectancy Questionnaire (CEQ) score

    Time frame: After the first group session (Week 1)

    A 6-item measure of intervention credibility and improvement expectancy, administered to assess and control for non-specific expectancy effects as a covariate in primary efficacy analyses.

Study contacts

Contact information is provided by the study sponsor or research team.

Qinsi Zheng

CONTACT

[email protected]

+86 13457651658

Xinghua Liu

CONTACT

[email protected]

+86 13371669818

Sponsors and collaborators

Lead sponsor

Peking University

Other

Registry information

Official study title

Effects and Multimodal EEG Mechanisms of an 8-week Mindfulness Intervention for Emotional Distress: A Randomized Controlled Trial

Acronym: MIED-RCT

Important dates

Study start
2026
Primary completion
2026
Study completion
2027
First posted
Jul 9, 2026
Registry last updated
Jul 28, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.